The FDA has approved Mounjaro (tirzepatide) from Lilly (LLY) for the purpose of decreasing cardiovascular risk in adults suffering from type 2 diabetes.

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.